na 931 vs retatrutide produces up to 30.3% weight loss in Phase 3 trial NA-931 Peptide: A Quadruple-Agonist Breakthrough

This support is vital for a healthy diet and may reduce the risk of cancer

Who qualifies for B12 injections

A 2026 study in The Lancet Obstetrics, Gynaecology, & Women's Health found that combining GLP-1s and hormonal therapy could result in a 35% increase in weight loss

Why Does Synthetic Peptide Identity Need Verification

These are wellness peptides, and they are distinct from the GLP-1 medications used in our weight loss program

These findings highlight the critical role of THC-induced oxidative stress as a contributing factor to cannabinoid-mediated neuropsychiatric risk and identifies a novel antioxidant treatment candidate for the prevention and/or reversal of these pathophysiological outcomes